We also elucidate the pathophysiological mechanisms of SF3B1 mutations in MDS development and progression, especially regarding disease features of MDS, such as impaired erythropoiesis, dysregulated iron metabolic homeostasis, hyperinflammatory features, and R-loop accumulation. Here, SF3B1 is linked to myelodysplastic syndrome.